$BOLD Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Audentes Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Audentes Therapeutics, Inc.. Get notifications about new insider transactions in Audentes Therapeutics, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 12 2018 | BOLD | Audentes Therapeut ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 36.04 | 1,066 | 38,419 | 3,556,934 | 3.6 M to 3.6 M (-0.03 %) |
Mar 12 2018 | BOLD | Audentes Therapeut ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 36.44 | 11,305 | 411,954 | 3,558,000 | 3.6 M to 3.6 M (-0.32 %) |
Mar 12 2018 | BOLD | Audentes Therapeut ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 35.86 | 47,395 | 1,699,585 | 3,569,305 | 3.6 M to 3.6 M (-1.31 %) |
Mar 12 2018 | BOLD | Audentes Therapeut ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 34.67 | 21,300 | 738,471 | 3,616,700 | 3.6 M to 3.6 M (-0.59 %) |
Mar 12 2018 | BOLD | Audentes Therapeut ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 34.06 | 58,428 | 1,990,058 | 3,638,000 | 3.7 M to 3.6 M (-1.58 %) |
Mar 06 2018 | BOLD | Audentes Therapeut ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 33.03 | 11,372 | 375,617 | 3,696,428 | 3.7 M to 3.7 M (-0.31 %) |
Mar 06 2018 | BOLD | Audentes Therapeut ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 36.06 | 200 | 7,212 | 3,707,800 | 3.7 M to 3.7 M (-0.01 %) |
Mar 06 2018 | BOLD | Audentes Therapeut ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 36.33 | 35,558 | 1,291,822 | 3,708,000 | 3.7 M to 3.7 M (-0.95 %) |
Mar 06 2018 | BOLD | Audentes Therapeut ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 35.06 | 386,080 | 13,535,965 | 3,743,558 | 4.1 M to 3.7 M (-9.35 %) |
Jan 19 2018 | BOLD | Audentes Therapeut ... | Goldberg Mark Alan | Director | Option Exercise | A | 38.00 | 4,500 | 171,000 | 4,500 | |
Jan 19 2018 | BOLD | Audentes Therapeut ... | Goldberg Mark Alan | Director | Option Exercise | A | 33.91 | 18,000 | 610,380 | 18,000 | |
Dec 26 2017 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 30.87 | 1,000 | 30,873 | 4,558 | 5.6 K to 4.6 K (-17.99 %) |
Dec 26 2017 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 30.86 | 1,000 | 30,858 | 21,678 | 22.7 K to 21.7 K (-4.41 %) |
Dec 26 2017 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 30.90 | 1,000 | 30,902 | 10,555 | 11.6 K to 10.6 K (-8.65 %) |
Dec 26 2017 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 30.88 | 15,000 | 463,160 | 425,799 | 440.8 K to 425.8 K (-3.40 %) |
Dec 05 2017 | BOLD | Audentes Therapeut ... | PRASAD SUYASH | Senior VP & Chief M ... | Option Exercise | M | 0.79 | 8,000 | 6,320 | 80,870 | |
Dec 05 2017 | BOLD | Audentes Therapeut ... | PRASAD SUYASH | Senior VP & Chief M ... | Sell | S | 28.98 | 1,230 | 35,651 | 0 | 1.2 K to 0 (-100.00 %) |
Dec 05 2017 | BOLD | Audentes Therapeut ... | PRASAD SUYASH | Senior VP & Chief M ... | Buy | M | 0.79 | 1,230 | 972 | 1,230 | 0 to 1.2 K |
Dec 05 2017 | BOLD | Audentes Therapeut ... | PRASAD SUYASH | Senior VP & Chief M ... | Sell | S | 28.45 | 6,770 | 192,613 | 0 | 6.8 K to 0 (-100.00 %) |
Dec 05 2017 | BOLD | Audentes Therapeut ... | PRASAD SUYASH | Senior VP & Chief M ... | Buy | M | 0.79 | 6,770 | 5,348 | 6,770 | 0 to 6.8 K |
Nov 17 2017 | BOLD | Audentes Therapeut ... | Soloway Thomas P | Senior Vice Preside ... | Option Exercise | A | 27.39 | 75,000 | 2,054,250 | 75,000 | |
Nov 17 2017 | BOLD | Audentes Therapeut ... | PRASAD SUYASH | Senior VP & Chief M ... | Option Exercise | A | 27.39 | 75,000 | 2,054,250 | 75,000 | |
Nov 17 2017 | BOLD | Audentes Therapeut ... | Patterson Matthew R | President & CEO | Option Exercise | A | 27.39 | 225,000 | 6,162,750 | 225,000 | |
Nov 17 2017 | BOLD | Audentes Therapeut ... | NEWMAN MARY | SVP, Regulatory Aff ... | Option Exercise | A | 27.39 | 50,000 | 1,369,500 | 50,000 | |
Nov 17 2017 | BOLD | Audentes Therapeut ... | NEWMAN MARY | SVP, Regulatory Aff ... | Option Exercise | M | 2.19 | 10,000 | 21,900 | 33,817 | |
Nov 17 2017 | BOLD | Audentes Therapeut ... | NEWMAN MARY | SVP, Regulatory Aff ... | Sell | S | 27.31 | 4,260 | 116,342 | 0 | 4.3 K to 0 (-100.00 %) |
Nov 17 2017 | BOLD | Audentes Therapeut ... | NEWMAN MARY | SVP, Regulatory Aff ... | Buy | M | 2.19 | 4,260 | 9,329 | 4,260 | 0 to 4.3 K |
Nov 17 2017 | BOLD | Audentes Therapeut ... | NEWMAN MARY | SVP, Regulatory Aff ... | Sell | S | 26.49 | 5,740 | 152,033 | 0 | 5.7 K to 0 (-100.00 %) |
Nov 17 2017 | BOLD | Audentes Therapeut ... | NEWMAN MARY | SVP, Regulatory Aff ... | Buy | M | 2.19 | 5,740 | 12,571 | 5,740 | 0 to 5.7 K |
Nov 17 2017 | BOLD | Audentes Therapeut ... | Nagler David | SVP, HR & Corp. Aff ... | Option Exercise | A | 27.39 | 50,000 | 1,369,500 | 50,000 | |
Nov 17 2017 | BOLD | Audentes Therapeut ... | Holles Natalie C. | Senior Vice Preside ... | Option Exercise | A | 27.39 | 100,000 | 2,739,000 | 100,000 | |
Nov 17 2017 | BOLD | Audentes Therapeut ... | GRAY JOHN T. | SVP, Chief Scientif ... | Option Exercise | A | 27.39 | 75,000 | 2,054,250 | 75,000 | |
Oct 10 2017 | BOLD | Audentes Therapeut ... | SQUINTO STEPHEN P | Director | Option Exercise | A | 26.01 | 9,000 | 234,090 | 9,000 | |
Oct 10 2017 | BOLD | Audentes Therapeut ... | Smith Julie | Director | Option Exercise | A | 26.01 | 9,000 | 234,090 | 9,000 | |
Oct 10 2017 | BOLD | Audentes Therapeut ... | Schuetz Thomas J. | Director | Option Exercise | A | 26.01 | 9,000 | 234,090 | 9,000 | |
Oct 10 2017 | BOLD | Audentes Therapeut ... | PARMAR KUSH | Director | Option Exercise | A | 26.01 | 9,000 | 234,090 | 9,000 | |
Oct 10 2017 | BOLD | Audentes Therapeut ... | Morrison Scott W | Director | Option Exercise | A | 26.01 | 9,000 | 234,090 | 9,000 | |
Oct 10 2017 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Option Exercise | A | 26.01 | 9,000 | 234,090 | 9,000 | |
Oct 10 2017 | BOLD | Audentes Therapeut ... | Jarrett Jennifer | Director | Option Exercise | A | 26.01 | 9,000 | 234,090 | 9,000 | |
Oct 04 2017 | BOLD | Audentes Therapeut ... | Patterson Matthew R | President & CEO | Option Exercise | M | 0.78 | 10,000 | 7,800 | 199,750 | |
Oct 04 2017 | BOLD | Audentes Therapeut ... | Patterson Matthew R | President & CEO | Sell | S | 27.92 | 15,000 | 418,853 | 171,814 | 186.8 K to 171.8 K (-8.03 %) |
Oct 04 2017 | BOLD | Audentes Therapeut ... | Patterson Matthew R | President & CEO | Sell | S | 27.92 | 10,000 | 279,217 | 0 | 10 K to 0 (-100.00 %) |
Oct 04 2017 | BOLD | Audentes Therapeut ... | Patterson Matthew R | President & CEO | Buy | M | 0.78 | 10,000 | 7,800 | 10,000 | 0 to 10 K |
Sep 29 2017 | BOLD | Audentes Therapeut ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 28.25 | 672,000 | 18,984,000 | 4,129,638 | 4.8 M to 4.1 M (-14.00 %) |
Sep 29 2017 | BOLD | Audentes Therapeut ... | Nagler David | SVP, HR & Corp. Aff ... | Option Exercise | M | 2.19 | 3,750 | 8,195 | 37,347 | |
Sep 29 2017 | BOLD | Audentes Therapeut ... | Nagler David | SVP, HR & Corp. Aff ... | Sell | S | 30.00 | 3,750 | 112,500 | 0 | 3.8 K to 0 (-100.00 %) |
Sep 29 2017 | BOLD | Audentes Therapeut ... | Nagler David | SVP, HR & Corp. Aff ... | Buy | M | 2.19 | 3,750 | 8,195 | 3,750 | 0 to 3.8 K |
Sep 29 2017 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 29.25 | 200 | 5,849 | 5,558 | 5.8 K to 5.6 K (-3.47 %) |
Sep 29 2017 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 28.14 | 1,800 | 50,648 | 5,758 | 7.6 K to 5.8 K (-23.82 %) |
Sep 29 2017 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 29.24 | 200 | 5,848 | 22,678 | 22.9 K to 22.7 K (-0.87 %) |
Sep 29 2017 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 28.14 | 1,800 | 50,655 | 22,878 | 24.7 K to 22.9 K (-7.29 %) |
Sep 29 2017 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 29.26 | 300 | 8,778 | 11,555 | 11.9 K to 11.6 K (-2.53 %) |
Sep 29 2017 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 28.12 | 1,700 | 47,810 | 11,855 | 13.6 K to 11.9 K (-12.54 %) |
Sep 29 2017 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 29.32 | 756 | 22,165 | 440,799 | 441.6 K to 440.8 K (-0.17 %) |
Sep 29 2017 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 28.31 | 4,244 | 120,150 | 441,555 | 445.8 K to 441.6 K (-0.95 %) |
Sep 26 2017 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 28.88 | 359 | 10,366 | 7,558 | 7.9 K to 7.6 K (-4.53 %) |
Sep 26 2017 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 28.07 | 641 | 17,991 | 7,917 | 8.6 K to 7.9 K (-7.49 %) |
Sep 26 2017 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 28.85 | 364 | 10,501 | 24,678 | 25 K to 24.7 K (-1.45 %) |
Sep 26 2017 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 28.06 | 636 | 17,847 | 25,042 | 25.7 K to 25 K (-2.48 %) |
Sep 26 2017 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 28.89 | 400 | 11,555 | 13,555 | 14 K to 13.6 K (-2.87 %) |
Sep 26 2017 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 27.99 | 600 | 16,796 | 13,955 | 14.6 K to 14 K (-4.12 %) |
Sep 26 2017 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 28.76 | 7,594 | 218,428 | 445,799 | 453.4 K to 445.8 K (-1.67 %) |
Sep 26 2017 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 27.85 | 7,406 | 206,244 | 453,393 | 460.8 K to 453.4 K (-1.61 %) |
Sep 19 2017 | BOLD | Audentes Therapeut ... | Patterson Matthew R | President & CEO | Option Exercise | M | 0.78 | 8,458 | 6,597 | 209,750 | |
Sep 19 2017 | BOLD | Audentes Therapeut ... | Patterson Matthew R | President & CEO | Option Exercise | M | 0.78 | 1,542 | 1,203 | 218,208 | |
Sep 19 2017 | BOLD | Audentes Therapeut ... | Patterson Matthew R | President & CEO | Sell | S | 25.07 | 8,458 | 212,010 | 0 | 8.5 K to 0 (-100.00 %) |
Sep 19 2017 | BOLD | Audentes Therapeut ... | Patterson Matthew R | President & CEO | Buy | M | 0.78 | 8,458 | 6,597 | 8,458 | 0 to 8.5 K |
Sep 19 2017 | BOLD | Audentes Therapeut ... | Patterson Matthew R | President & CEO | Sell | S | 25.00 | 1,542 | 38,551 | 0 | 1.5 K to 0 (-100.00 %) |
Sep 19 2017 | BOLD | Audentes Therapeut ... | Patterson Matthew R | President & CEO | Buy | M | 0.78 | 1,542 | 1,203 | 1,542 | 0 to 1.5 K |
Sep 19 2017 | BOLD | Audentes Therapeut ... | Nagler David | SVP, HR & Corp. Aff ... | Option Exercise | M | 2.19 | 3,750 | 8,195 | 41,097 | |
Sep 19 2017 | BOLD | Audentes Therapeut ... | Nagler David | SVP, HR & Corp. Aff ... | Sell | S | 25.00 | 3,750 | 93,750 | 0 | 3.8 K to 0 (-100.00 %) |
Sep 19 2017 | BOLD | Audentes Therapeut ... | Nagler David | SVP, HR & Corp. Aff ... | Buy | M | 2.19 | 3,750 | 8,195 | 3,750 | 0 to 3.8 K |
Sep 11 2017 | BOLD | Audentes Therapeut ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | X | 15.03 | 5,000 | 75,150 | 0 | |
Sep 11 2017 | BOLD | Audentes Therapeut ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 22.35 | 5,000 | 111,750 | 4,801,638 | 4.8 M to 4.8 M (-0.10 %) |
Sep 11 2017 | BOLD | Audentes Therapeut ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | X | 15.03 | 5,000 | 75,150 | 4,806,638 | 4.8 M to 4.8 M (+0.10 %) |
Sep 01 2017 | BOLD | Audentes Therapeut ... | PRASAD SUYASH | Senior VP & Chief M ... | Option Exercise | M | 0.79 | 8,000 | 6,320 | 88,870 | |
Sep 01 2017 | BOLD | Audentes Therapeut ... | PRASAD SUYASH | Senior VP & Chief M ... | Sell | S | 21.44 | 8,000 | 171,481 | 0 | 8 K to 0 (-100.00 %) |
Sep 01 2017 | BOLD | Audentes Therapeut ... | PRASAD SUYASH | Senior VP & Chief M ... | Buy | M | 0.79 | 8,000 | 6,320 | 8,000 | 0 to 8 K |
Aug 25 2017 | BOLD | Audentes Therapeut ... | NEWMAN MARY | SVP, Regulatory Aff ... | Option Exercise | M | 2.19 | 10,000 | 21,900 | 43,817 | |
Aug 25 2017 | BOLD | Audentes Therapeut ... | NEWMAN MARY | SVP, Regulatory Aff ... | Sell | S | 20.00 | 10,000 | 200,000 | 0 | 10 K to 0 (-100.00 %) |
Aug 25 2017 | BOLD | Audentes Therapeut ... | NEWMAN MARY | SVP, Regulatory Aff ... | Buy | M | 2.19 | 10,000 | 21,900 | 10,000 | 0 to 10 K |
Jul 14 2017 | BOLD | Audentes Therapeut ... | Patterson Matthew R | President & CEO | Sell | S | 20.00 | 12,150 | 243,052 | 186,814 | 199 K to 186.8 K (-6.11 %) |
Jul 14 2017 | BOLD | Audentes Therapeut ... | Patterson Matthew R | President & CEO | Sell | S | 20.00 | 2,850 | 57,007 | 198,964 | 201.8 K to 199 K (-1.41 %) |
Jun 28 2017 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 20.59 | 7,176 | 147,738 | 460,799 | 468 K to 460.8 K (-1.53 %) |
Jun 28 2017 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 19.52 | 2,824 | 55,128 | 467,975 | 470.8 K to 468 K (-0.60 %) |
Jun 28 2017 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 18.76 | 5,000 | 93,817 | 470,799 | 475.8 K to 470.8 K (-1.05 %) |
Jun 13 2017 | BOLD | Audentes Therapeut ... | Jarrett Jennifer | Director | Option Exercise | A | 14.70 | 18,000 | 264,600 | 18,000 | |
Jun 01 2017 | BOLD | Audentes Therapeut ... | Holles Natalie C. | Senior Vice Preside ... | Option Exercise | M | 2.76 | 20,000 | 55,200 | 169,819 | |
Jun 01 2017 | BOLD | Audentes Therapeut ... | Holles Natalie C. | Senior Vice Preside ... | Buy | M | 2.76 | 20,000 | 55,200 | 20,000 | 0 to 20 K |
Apr 26 2017 | BOLD | Audentes Therapeut ... | 5AM Partners III, LLC | Buy | P | 14.50 | 168,082 | 2,437,189 | 2,500,113 | 2.3 M to 2.5 M (+7.21 %) | |
Apr 26 2017 | BOLD | Audentes Therapeut ... | 5AM Partners III, LLC | Buy | P | 14.50 | 4,331 | 62,800 | 64,431 | 60.1 K to 64.4 K (+7.21 %) | |
Jan 27 2017 | BOLD | Audentes Therapeut ... | Soloway Thomas P | Senior Vice Preside ... | Option Exercise | A | 15.26 | 80,000 | 1,220,800 | 80,000 | |
Jan 27 2017 | BOLD | Audentes Therapeut ... | PRASAD SUYASH | Senior VP & Chief M ... | Option Exercise | A | 15.26 | 70,000 | 1,068,200 | 70,000 | |
Jan 27 2017 | BOLD | Audentes Therapeut ... | Patterson Matthew R | President & CEO | Option Exercise | A | 15.26 | 200,000 | 3,052,000 | 200,000 | |
Jan 27 2017 | BOLD | Audentes Therapeut ... | NEWMAN MARY | SVP, Regulatory Aff ... | Option Exercise | A | 15.26 | 50,000 | 763,000 | 50,000 | |
Jan 27 2017 | BOLD | Audentes Therapeut ... | Nagler David | SVP, HR & Corp. Aff ... | Option Exercise | A | 15.26 | 50,000 | 763,000 | 50,000 | |
Jan 27 2017 | BOLD | Audentes Therapeut ... | Holles Natalie C. | Senior Vice Preside ... | Option Exercise | A | 15.26 | 115,000 | 1,754,900 | 115,000 | |
Jan 27 2017 | BOLD | Audentes Therapeut ... | GRAY JOHN T. | Senior Vice Preside ... | Option Exercise | A | 15.26 | 70,000 | 1,068,200 | 70,000 | |
Jan 05 2017 | BOLD | Audentes Therapeut ... | Smith Julie | Director | Option Exercise | A | 17.85 | 18,000 | 321,300 | 18,000 | |
Aug 25 2016 | BOLD | Audentes Therapeut ... | Woiwode Thomas | Director | Option Exercise | A | 15.03 | 18,000 | 270,540 | 18,000 | |
Aug 25 2016 | BOLD | Audentes Therapeut ... | SQUINTO STEPHEN P | Director | Option Exercise | A | 15.03 | 9,000 | 135,270 | 9,000 | |
Aug 25 2016 | BOLD | Audentes Therapeut ... | SILVERSTEIN JONATHAN | Director | Option Exercise | A | 15.03 | 18,000 | 270,540 | 18,000 | |
Aug 25 2016 | BOLD | Audentes Therapeut ... | Schuetz Thomas J. | Director | Option Exercise | A | 15.03 | 9,000 | 135,270 | 9,000 | |
Aug 25 2016 | BOLD | Audentes Therapeut ... | PARMAR KUSH | Director | Option Exercise | A | 15.03 | 18,000 | 270,540 | 18,000 | |
Aug 25 2016 | BOLD | Audentes Therapeut ... | Morrison Scott W | Director | Option Exercise | A | 15.03 | 9,000 | 135,270 | 9,000 | |
Aug 25 2016 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Option Exercise | A | 15.03 | 18,000 | 270,540 | 18,000 | |
Jul 25 2016 | BOLD | Audentes Therapeut ... | Woiwode Thomas | Director | Option Exercise | C | 0.00 | 1,249 | 0 | 0 | |
Jul 25 2016 | BOLD | Audentes Therapeut ... | Woiwode Thomas | Director | Option Exercise | C | 0.00 | 3,029 | 0 | 0 | |
Jul 25 2016 | BOLD | Audentes Therapeut ... | Woiwode Thomas | Director | Option Exercise | C | 0.00 | 6,811 | 0 | 0 | |
Jul 25 2016 | BOLD | Audentes Therapeut ... | Woiwode Thomas | Director | Option Exercise | C | 0.00 | 198,410 | 0 | 0 | |
Jul 25 2016 | BOLD | Audentes Therapeut ... | Woiwode Thomas | Director | Option Exercise | C | 0.00 | 480,856 | 0 | 0 | |
Jul 25 2016 | BOLD | Audentes Therapeut ... | Woiwode Thomas | Director | Option Exercise | C | 0.00 | 1,081,477 | 0 | 0 | |
Jul 25 2016 | BOLD | Audentes Therapeut ... | Woiwode Thomas | Director | Buy | P | 15.00 | 219 | 3,285 | 11,308 | 11.1 K to 11.3 K (+1.97 %) |
Jul 25 2016 | BOLD | Audentes Therapeut ... | Woiwode Thomas | Director | Buy | P | 15.00 | 34,781 | 521,715 | 1,795,524 | 1.8 M to 1.8 M (+1.98 %) |
Jul 25 2016 | BOLD | Audentes Therapeut ... | Woiwode Thomas | Director | Buy | C | 0.00 | 1,249 | 0 | 11,089 | 9.8 K to 11.1 K (+12.69 %) |
Jul 25 2016 | BOLD | Audentes Therapeut ... | Woiwode Thomas | Director | Buy | C | 0.00 | 3,029 | 0 | 9,840 | 6.8 K to 9.8 K (+44.47 %) |
Jul 25 2016 | BOLD | Audentes Therapeut ... | Woiwode Thomas | Director | Buy | C | 0.00 | 6,811 | 0 | 6,811 | 0 to 6.8 K |
Jul 25 2016 | BOLD | Audentes Therapeut ... | Woiwode Thomas | Director | Buy | C | 0.00 | 198,410 | 0 | 1,760,743 | 1.6 M to 1.8 M (+12.70 %) |
Jul 25 2016 | BOLD | Audentes Therapeut ... | Woiwode Thomas | Director | Buy | C | 0.00 | 480,856 | 0 | 1,562,333 | 1.1 M to 1.6 M (+44.46 %) |
Jul 25 2016 | BOLD | Audentes Therapeut ... | Woiwode Thomas | Director | Buy | C | 0.00 | 1,081,477 | 0 | 1,081,477 | 0 to 1.1 M |
Jul 25 2016 | BOLD | Audentes Therapeut ... | Versant Ventures IV, LLC | 10% Owner | Option Exercise | C | 0.00 | 1,249 | 0 | 0 | |
Jul 25 2016 | BOLD | Audentes Therapeut ... | Versant Ventures IV, LLC | 10% Owner | Option Exercise | C | 0.00 | 3,029 | 0 | 0 | |
Jul 25 2016 | BOLD | Audentes Therapeut ... | Versant Ventures IV, LLC | 10% Owner | Option Exercise | C | 0.00 | 6,811 | 0 | 0 | |
Jul 25 2016 | BOLD | Audentes Therapeut ... | Versant Ventures IV, LLC | 10% Owner | Option Exercise | C | 0.00 | 198,410 | 0 | 0 | |
Jul 25 2016 | BOLD | Audentes Therapeut ... | Versant Ventures IV, LLC | 10% Owner | Option Exercise | C | 0.00 | 480,856 | 0 | 0 | |
Jul 25 2016 | BOLD | Audentes Therapeut ... | Versant Ventures IV, LLC | 10% Owner | Option Exercise | C | 0.00 | 1,081,477 | 0 | 0 | |
Jul 25 2016 | BOLD | Audentes Therapeut ... | Versant Ventures IV, LLC | 10% Owner | Buy | P | 15.00 | 219 | 3,285 | 11,308 | 11.1 K to 11.3 K (+1.97 %) |
Jul 25 2016 | BOLD | Audentes Therapeut ... | Versant Ventures IV, LLC | 10% Owner | Buy | P | 15.00 | 34,781 | 521,715 | 1,795,524 | 1.8 M to 1.8 M (+1.98 %) |
Jul 25 2016 | BOLD | Audentes Therapeut ... | Versant Ventures IV, LLC | 10% Owner | Buy | C | 0.00 | 1,249 | 0 | 11,089 | 9.8 K to 11.1 K (+12.69 %) |
Jul 25 2016 | BOLD | Audentes Therapeut ... | Versant Ventures IV, LLC | 10% Owner | Buy | C | 0.00 | 3,029 | 0 | 9,840 | 6.8 K to 9.8 K (+44.47 %) |
Jul 25 2016 | BOLD | Audentes Therapeut ... | Versant Ventures IV, LLC | 10% Owner | Buy | C | 0.00 | 6,811 | 0 | 6,811 | 0 to 6.8 K |
Jul 25 2016 | BOLD | Audentes Therapeut ... | Versant Ventures IV, LLC | 10% Owner | Buy | C | 0.00 | 198,410 | 0 | 1,760,743 | 1.6 M to 1.8 M (+12.70 %) |
Jul 25 2016 | BOLD | Audentes Therapeut ... | Versant Ventures IV, LLC | 10% Owner | Buy | C | 0.00 | 480,856 | 0 | 1,562,333 | 1.1 M to 1.6 M (+44.46 %) |
Jul 25 2016 | BOLD | Audentes Therapeut ... | Versant Ventures IV, LLC | 10% Owner | Buy | C | 0.00 | 1,081,477 | 0 | 1,081,477 | 0 to 1.1 M |
Jul 25 2016 | BOLD | Audentes Therapeut ... | SILVERSTEIN JONATHAN | Director | Option Exercise | C | 0.00 | 332,766 | 0 | 0 | |
Jul 25 2016 | BOLD | Audentes Therapeut ... | SILVERSTEIN JONATHAN | Director | Option Exercise | C | 0.00 | 1,071,992 | 0 | 0 | |
Jul 25 2016 | BOLD | Audentes Therapeut ... | SILVERSTEIN JONATHAN | Director | Option Exercise | C | 0.00 | 2,511,441 | 0 | 0 | |
Jul 25 2016 | BOLD | Audentes Therapeut ... | SILVERSTEIN JONATHAN | Director | Option Exercise | C | 0.00 | 627,867 | 0 | 0 | |
Jul 25 2016 | BOLD | Audentes Therapeut ... | SILVERSTEIN JONATHAN | Director | Buy | P | 15.00 | 33,334 | 500,010 | 4,801,638 | 4.8 M to 4.8 M (+0.70 %) |
Jul 25 2016 | BOLD | Audentes Therapeut ... | SILVERSTEIN JONATHAN | Director | Buy | C | 0.00 | 332,766 | 0 | 4,768,304 | 4.4 M to 4.8 M (+7.50 %) |
Jul 25 2016 | BOLD | Audentes Therapeut ... | SILVERSTEIN JONATHAN | Director | Buy | C | 0.00 | 1,071,992 | 0 | 4,435,538 | 3.4 M to 4.4 M (+31.87 %) |
Jul 25 2016 | BOLD | Audentes Therapeut ... | SILVERSTEIN JONATHAN | Director | Buy | C | 0.00 | 2,511,441 | 0 | 3,363,546 | 852.1 K to 3.4 M (+294.73 %) |
Jul 25 2016 | BOLD | Audentes Therapeut ... | SILVERSTEIN JONATHAN | Director | Buy | C | 0.00 | 627,867 | 0 | 852,105 | 224.2 K to 852.1 K (+280.00 %) |
Jul 25 2016 | BOLD | Audentes Therapeut ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 332,766 | 0 | 0 | |
Jul 25 2016 | BOLD | Audentes Therapeut ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 1,071,992 | 0 | 0 | |
Jul 25 2016 | BOLD | Audentes Therapeut ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 2,511,441 | 0 | 0 | |
Jul 25 2016 | BOLD | Audentes Therapeut ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 627,867 | 0 | 0 | |
Jul 25 2016 | BOLD | Audentes Therapeut ... | ORBIMED ADVISORS LLC | Director | Buy | P | 15.00 | 33,334 | 500,010 | 4,801,638 | 4.8 M to 4.8 M (+0.70 %) |
Jul 25 2016 | BOLD | Audentes Therapeut ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 332,766 | 0 | 4,768,304 | 4.4 M to 4.8 M (+7.50 %) |
Jul 25 2016 | BOLD | Audentes Therapeut ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 1,071,992 | 0 | 4,435,538 | 3.4 M to 4.4 M (+31.87 %) |